Atlas Trials

Adjuvant Quisinostat in High-Risk Uveal Melanoma

Clinical trial NCT06932757 · RECRUITING

Trial details

NCT number
NCT06932757
Sponsor
University of Miami
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Uveal Melanoma
Start date
2025-05-27
Primary completion
2030-05-27
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.